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INTRODUCTION
Angiotensin II (Ang II) is a multifunctional peptide
hormone that not only controls cardiovascular ho-
meostasis but also promotes cell growth, migration
and inflammation. Ang II is also known to inhibit
insulin action on glucose uptake. Actin is a cellular
protein essential for the motility and cell signaling
of both non-muscle and muscle cells. In the muscle
cell dynamic actin polymerization and de-polymerization
is the basic mechanism of the cell signaling. The
cytoskeleton is a filamentous network consisting
largely of filamentous actin (F-actin), which provides
a scaffold on which signaling proteins, such as
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GLUT4 translocation to generate internal stress
and alter the amount of the glucose uptake of the
cells(1-5). However, the intracellular signaling
mechanisms governing on reorganization actin
filaments and effect on insulin signaling pathway
remains essentially undefined.
Many signal transduction pathways mediated by
Ang II actions, including the activation of janus
kinase, which phosphorylates and activates signal
transducers, activators of transcription factors, and
the stimulation of mitogen activated protein (MAP)
kinase pathway(6-8). Ang II receptor are also coupled
to a wide variety of signal transduction elements,
including protein kinase C (PKC), c-Src tyrosine
kinase, protein tyrosine phosphorylation, and ex-
tracellular signal-regulated kinase (ERK) 1/2(9).
In the present study, we investigate mechanism
by which Ang II inhibits insulin-induced actin ar-
rangement and glucose uptake in L6 myotube cells.
The aims of this investigation were (a) to clarify
mechanism of inhibition of glucose uptake by Ang
II and its relation to actin stress fiber formation, (b)
to determine the role of ERKs in insulin-induced
actin organization and glucose uptake in skeletal
muscle cells. The results indicate that insulin play
an important role in insulin-induced actin stress
fiber formation and organization as well as glucose
uptake and that Ang II inhibit both actions, at least
in part, through ERK 1/2 phosphorylation.
MATERIALS AND METHODS
Cells
In this study we used L6 myoblast (L6). In these
cells, we studied the effect of pretreatment of Ang
II on insulin signaling pathway using fluorescence
microscopy and glucose uptake. The L6 cells were
maintained in α-minimal essential medium (α-MEM,
Sigma, Saint Louis, Missouri) supplemented with
10% fetal bovine serum (FBS, ICN Biomedical Inc.,
Aurora, Ohio) (vol/vol) and gentamycin 100U/ml
in an atmosphere of 5% CO2 at 37℃. For actin
filament staining, the cells were treated with tryp-
sin and transferred into indicated dish and incu-
bated at 37℃ with 5% CO2. After 5-7 days, the cells
before reaching confluent were used for experi-
ments.
Colorimetric assay of actin filament staining
Cells in 3cm dish with cover slip were incubated in
2ml Krebs Ringer Hepes (KRH) buffer for 30min
at 37℃ and then incubated in 2ml 300nM insulin.
After fixation with 2% paraformaldehyde (10min,
room temperature), cells were washed with Phos-
phate Buffered Saline (PBS), and then incubated in
0.1% Triton X-100 in PBS for 10min at room tem-
perature. Cells were washed with PBS, and then
incubated in 1% BSA in PBS for 20min at room tem-
perature. The cells were extensively washed
with PBS buffer before and after introducing
rhodamine-phalloidin (Molecular Probes Inc.,
Leiden, The Netherlands) for 20min at room tem-
perature. Then, fluorescence microscopy was used
for detection of actin filaments. To determine the
actin filament status in cytoplasm, Adobe Photo
Shop was used to select for stained cells. Selected
regions were copied and pasted into a new RGB
channel.
Determination of 2-deoxy-[3H] D-glucose uptake
in cells in culture
Glucose uptake was measured on differentiated
cells grown in 24-well plates using 2-deoxy-[3H] D-
glucose (Muromachi, Japan). Briefly, the cells were
pre-incubated at 37℃ for 4h in serum-free medium
containing 10mM cold glucose for starvation after
washing with serum-free medium. To ensure that
the cells were in the basal state at the beginning of
experiment, the cells were washed 3 times in KRH
buffer (KRH/0.1% BSA) and pre-incubation cells
with KRH/0.1% BSA at 37℃ for 20 min. Cells were
treated with indicated concentrations of ligands
for indicated periods at 37℃. Hexose uptake was
measured at room temperature for 10 min in trans-
port buffer containing : 0.5 M HEPES, 1 MMgSO4,
1M CaCl2, 2M KCl, 5M NaCl and 50μM2-deoxy-[3H]
D-glucose (1mCi/ml). After cells were exposure
to 2-deoxy-[3H] D-glucose for 10min, the cells were
washed 4 times in KRH/ 0.1% BSA/phloretin and
solublized in 0.1% sodium dodecyl sulfate (SDS) ;
the cell-associated radioactivity was measured.
Cellular protein content was measured by the bi-
cinchoninic acid (BCA) method.
Western blot analysis
Growth-arrested L6 cells were either left un-
treated or stimulated by Ang II, insulin, PD 98059,
RNH 6270 and others. Cells were lysed with lysis
buffer containing 20mM Tris-Hcl, pH 7.4, 150 mM
NaCl, 1% Sodium deoxycholate, 0.1% SDS, 1%
Nonodet-P40, 2mM EDTA (2Na) and 1mM phenyl-
methylsulfonyl fluoride. Equal amounts of cellular
protein were analyzed by SDS-polyacrylamide gel
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electrophoresis (SDS-PAGE) and electro trans-
ferred to PVDF membranes, and probed with the
indicated antibodies. The membranes were than
subjected to immunoblotting with a rabbit polyclo-
nal Akt antibody, an ERK 1/2 antibody, a phospho-
Akt (Ser-473) antibody and a phospho-ERK 1/2
(phospho 44/42 MAP kinase, Thr 202 and Tyr 204
respectively) antibody. Secondary antibodies were
coupled to horseradish peroxidase, HRP-conjugated
goat anti-rabbit IgG, andWestern blot detection was
done by enhanced chemiluminescence (ECL, Am-
ersham Pharmacia Biotech). All of the antibodies
were purchase from Santa Cruz Biotechnology
Inc. (Santa Cruz, California).
Statistical analysis
Data are presented as the mean ±standard de-
viation and were performed using ANOVA plus
Bonferroni multiple comparison tests. Values of p<
0.05 were considered significantly different.
RESULTS
Insulin stimulates actin stress fiber formation
Before insulin stimulation, the fluorescent inten-
sity of actin fibers in the cytoplasm of L6 myotube
cells was minimal. There was an increase in actin
fiber polymerization after 10min incubation with
300 nM insulin (Fig.1A upper panel), resulting in
the reorientation of fibers with the long axis of the
cells (stress fiber formation). Insulin also signifi-
cantly increased glucose uptake (Fig. 1C).
Ang II inhibits actin stress fiber formation and glucose
uptake through AT 1 receptor
Ang II is known to inhibit insulin signaling and
glucose uptake. We examined the effect of pretreat-
ment of Ang II on insulin-induced actin organiza-
tion. The lower panel of Fig. 1A shows, when the cell
was exposed to 100nM Ang II for 60 minutes, insulin-
induced stress fiber formation was abolished. In
Fig. 1. Effect of Ang II on insulin-induced actin stress fiber forma-
tion and glucose uptake through AT 1 receptor.
Actin stress fibers were observed under a fluorescence microscope.
A : Actin staining shows that insulin stimulates the formation of actin
stress fibers (Ins., straight red fiber-like strands along the long axis)
comparison with control (Con.) in L6 cells. Cells were preincubated
with 100 nM Ang II for 60 min and stimulated by 300 nM insulin for
10 min. Insulin-induced formation of actin stress fibers in cells was
completely blocked by pretreatment of Ang II (Ang II, Ins.) as well as
Ang II (Ang II). B:The insulin-induced formation of actin stress fibers
was not improved by treatment with 10 μM PD 123319 (an AT2 re-
ceptor blocker, 1B lower panel) for 30 min but completely reversed
by treatment with 100 nM RNH-6270 (an AT 1 receptor blocker, 1 B
upper panel). C : Cells were pretreated with RNH-6270 before treat-
ment with Ang II or pretreatment of Ang II. The total amount of 2-
deoxy-[3H] D-glucose uptake into the cells during last 10 min incuba-
tion wasmeasured as described in materials andmethod.Bar graph quan-
tization of five experiments is shown ; significant differences (* P<
0.05)are indicated.
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order to check whether this blocking effect of Ang
II is mediated by AT1 receptor, we examined the
effect of RNH-6270, an AT1 receptor blocker, an
active form of olmesartan, on pretreatment of Ang
II. When the cells were exposed to 100nM RNH-
6270, blocking effect of Ang II on insulin-induced
stress fiber formation was completely reversed
(Fig. 1B upper panel). To verify whether altered Ang
II signaling is due to changes in Ang II receptors
status, we examined AT1/AT2 receptor antago-
nist, saralasin, and AT2 receptor antagonist, PD
123319, on pretreatment and treatment of Ang
II. Ang II-induced effects were blocked by salarasin
(data not down) but not significantly by PD 123319
(Fig. 1B lower panel). Figure 1C shows that glucose
uptake was significantly (p<0.001) increased in the
presence of 300nM insulin for 10 minutes. Pre-
treatment of Ang II significantly decreased insulin-
induced glucose uptake. The inhibition of glucose
uptake with Ang II was reversed by AT1 blocker, RNH
6270, suggesting that Ang II inhibits actin reor-
ganization and glucose uptake through AT 1 re-
ceptor.
Ang II inhibited insulin-stimulated glucose uptake is not
through GTP[S] pathway
We also investigated GTP[S] pathways, an impor-
tant pathway of Ang II. Pretreatment of 100μMGDP-
β-S, a G protein inhibitor, for 10 minutes did not
reverse the inhibitory effect of Ang II on insulin-
stimulated glucose uptake and actin stress fiber
formation (Fig. 2A and 2B). However, in the pres-
ence of G protein inhibitor, actin intensities in the
peripheral area of the cells (cortical actin filament)
Fig. 2．Ang II inhibited insulin-stimulated glucose uptake is not through GTP[S] pathway.
A : In the presence of 100 μM [GDP-β-S], a G protein inhibitor, for 10 minutes, the inhibitory effect of pretreatment of Ang II on
insulin-stimulated glucose uptake did not improve. B : G protein inhibitor did not return actin filament disarrangement by Ang II or
pretreatment of Ang II (Ang II, Ins.). C and D : The effect of Ang II on insulin-induced Akt and ERK 1/2 phosphorylation and also
influences of G-protein inhibitor (Gi) on Ang II impairment of Akt phosphorylation by insulin (Ins.). Cell lyses were immunoblotted
by phospho-Akt (pAkt) and ERK 1/2 (pERK 1/2). Figure C shows representative blots and figure D shows the densitometry analy-
ses. Values are normalized by arbitrarily setting the densitometry of control cells (without any stimulation) to 1(values are the mean
±SD, n=3).＊P <0.05 vs. control cells.
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become strong. Akt phosphorylation is a major
pathway of insulin signaling on glucose uptake.
Figures 2C and D (upper panels) show that Akt
phosphorylation was blocked by Ang II. G protein
inhibitor did not improve Ang II-induced inhibi-
tion of Akt phosphorylation. G protein inhibitor
also did not inhibit effect of Ang II or insulin on
ERK 1/2 phosphorylation in L6 cells (Fig. 2C and D
lower panel) suggesting that Ang II inhibited
insulin-induced Akt phosphorylation is independ-
ent on GTP[S] pathway.
Ang II inhibits insulin-induced actin stress fiber formation
and glucose uptake through ERK 1/2 signaling pathway
Ang II is also coupled to PKC and MAP kinase,
we studied the effect of various intracellular sig-
naling using specific inhibitors. By the treatment
of L6 cells with GF 109203X, a selective PKC in-
hibitor, and SB 203580, a p38 MAP kinase inhibi-
tor, Ang II-induced disarrangement of actin stress
fiber was not altered. PD 98059, a selective ERK 1/2
inhibitor, completely reversed Ang II-induced actin
disarrangement (Fig. 3 A), suggesting that this
inhibitory effect of Ang II was mediated by ERK
1/2 signaling pathway but not by PKC or p38 MAP
kinase signaling pathways. Figure 3B shows the
effect of inhibitors of Ang II signaling pathways on
glucose uptake in the presence of insulin. Pretreat-
ment of 10μM PD 98059 for 30 minutes, but not
those of 10μM GF 109203X or 10μM SB 203580
improved glucose uptake. These results suggest
that Ang II-induced suppression of insulin-stimulated
glucose uptake is also mediated by ERK 1/2 sig-
naling pathway.
ERK 1/2 phosphorylation by Ang II has negative effect
on insulin-induced Akt phosphorylation
Ang II has been reported to inhibit insulin signal-
ing at multiple levels in cells. Figures 4A and B show
the effect of pretreatment of Ang II on insulin-
induced Akt phosphorylation. Pretreatment of Ang
II significantly inhibited insulin-induced Akt phos-
phorylation. Treatment of PD 98059, an ERK 1/2
inhibitor, improved inhibitory effect of Ang II on
insulin-induced Akt phosphorylation.
We further studied relation between ERK 1/2 and
Fig. 3．Ang II inhibits insulin-induced actin stress fiber formation and glucose uptake through ERK 1/2 signaling pathway.
A : Actin staining by rhodamine-phalloidin shows the effects some of the elements on treatment of Ang II or pretreatment of Ang II
(Ang II, Ins.) on insulin-induced actin stress fiber formation. Treatment of L 6 cells with 10 μM PD 98059, completely improved Ang
II-induced disarrangement of actin stress fiber but not improved by 10 μM GF 109203 X or 10 μM SB 203580. B : The effect of Ang
II signaling pathways blockers on glucose uptake in the presence of 300 nM insulin. Bar graph quantization of five experiments is
shown ; significant differences (＊P<0.05 vs. control cells,†P<0.05 vs. insulin) are indicated.
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Akt phosphorylations. Expression of ERK 1/2 pro-
tein was detected as p42 and p44 ERKs. In figure 4
C, Ang II alone as well as insulin alone increased
ERK 1/2 phosphorylation, and greater phospho-
rylation occurred by combination of Ang II and
insulin. PD 98059 but not SB 203580, completely
blocked ERK 1/2 phosphorylation by Ang II in L6
cells (Fig. 4D). In addition PD 98059 also increased
phosphrylation of Akt in the presence of Ang II and
insulin suggesting that suppression of ERK 1/2
phosphorylation might increase Akt phosphoryla-
tion, a major pathway for insulin-stimulated glucose
uptake signaling. In the presence of insulin alone,
PD 98059 slightly but significantly improved glucose
uptake (Fig. 3B), suggesting that insulin enhances
phosphorylation of Akt and increase glucose uptake
through phosphatidylinositol 3-kinase (PI3-K) but
on the other hand insulin might inhibit glucose
uptake by ERK 1/2 phosphorylation.
Matrix Metalloproteinases (MMPs) are not involved in
Ang II-induced inhibition of actin stress fiber formation
Several studies have shown that various MMPs
play a critical role in the activation of the EGFR and
ERK 1/2 in response to diverse environmental
stimuli, including cigarette smoking and Ang II.
We therefore hypothesized that EGFR activation
may essential for inhibition by Ang II on actin stress
fiber formation and glucose uptake in L6 cells. To
examine this possibility, cells were treated with
GM 6001, a compound that broadly inhibits MMP
activation and specifically inhibits EGFR tyrosine
kinase activity, for 10min before Ang II exposure
and actin filaments were stained. We found that
Fig. 4．Effect of RNH-6270 on phosphorylation of ERK 1/2.
L6 cells were preincubated with PD 98059 (PD) and SB 203580 (SB) for 30 min or 100 nM RNH-6270,followed with treatment of Ang
II or pretreatment of Ang II (Ang II, Ins.) or treatment with insulin (Ins.). Cells were harvested, lysed and used for subsequent
measurement of Akt phosphorylation (pAkt), total Akt (Akt), ERK 1/2 phosphorylation (pERK 1/2)and total ERK 1/2(ERK 1/2)as
described in material and methods. A : Representative blots of pAkt and Akt, B : densitometry analyses of pAkt. C : Representative
blots of pERK 1/2 and ERK 1/2. D : PD 98059 significantly inhibited ERK 1/2 phosphorylation but SB 203580, a p38 MAP kinase
inhibitor, is no any effect on it. Figure D upper panel show representative blots and lower panel show the densitometry analyses.
Values are normalized by arbitrarily setting the densitometry of control cells (without any stimulation) to 1(values are the mean±
SD, n=3).＊P<0.05 vs. control cells.
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GM 6001 did not affect on Ang II-induced inhibition
of actin stress fiber formation (Fig. 5A). Western
blotting data shows, MMP inhibitor did not reverse
inhibitory effect of Ang II (Fig. 5B upper panel).
Figures 5B lower panel and 5C show that GM 6001
did not inhibit effect of Ang II or insulin on ERK 1/2
phosphorylation in L6 cells. The results suggest
that Ang II-inhibited insulin-induced actin organi-
zation and glucose uptake is independent onMMPs
activity as well as EGFR transactivation pathway in
L6 cells.
DISSCUSSION
In this study, we addressed the question of whether
Ang II-induced alterations in insulin signaling con-
tribute to impair glucose uptake and actin organi-
zation in skeletal muscle cells. Ang II inhibited
insulin-induced actin reorganization and glucose
uptake. Ang II also inhibited Akt phosphorylation,
a key pathway of insulin-induced glucose uptake.
Most notably is the observation that when ERK 1/2
activity is blocked by PD 98059, a selective inhibi-
tor of the ERK 1/2, actin rearrangement and glucose
uptake were improved in addition to Akt phospho-
rylation. Thus, the data suggest that ERK 1/2 sig-
naling pathway is key mediators of Ang II - mediated
actin filament disorganization and glucose uptake.
Molecular mechanisms whereby Ang II causes
actin disarrangement have not been fully elucidated
especially in skeletal muscle cells. The present study
demonstrates that disarrangement of actin filament
by Ang II results in impairing glucose uptake in L6
myotube cells. This occurred via AT1 receptor, as
deduced by the ability of the AT1antagonist, RNH-
6270, to reverse the inhibitory effect of Ang II. This
event was associated with impaired actin filament
disarrangement through activating of ERK 1/2 phos-
phorylation. The results indicate that inhibition of
ERK 1/2 signal transduction contributes to improve
actin stress fiber formation and glucose uptake. To
our knowledge, the present study demonstrates
for the first time that Ang II modulates of ERK 1/2
and actin disarrangement, consequently decrease in
glucose uptake.
Ang II has been shown to activate Akt via AT1
receptor in various cell types, including vascular
smooth muscle cells (10, 11-13). However, we found
opposite phenomenon and did not observe Ang II-
induced Akt activation in our study. This discrep-
ancy probably results from differences in cell types.
Ang II stimulated many intracellular signaling
pathway ; G protein and MAP kinase activities in
L6 myotube cells (14, 15). The present study showed
that an Ang II effects on insulin-induced actin dis-
organization is not mediated by these signaling
pathways. In addition, Ang II activates ERK 1/2 via
independent signaling pathways involving PKC,
guanosine 5’-O-(2-thiodiphosphate)-insensitive G
protein and p38 MAP kinase.
Activation of angiotensin receptor with Ang II
leads to reorganization of the actin cytoskeleton in
L6 myotube cells. However, scare information is
available on the cellular signaling pathways by
Ang II (7, 9, 11-13, 16). The present studies suggest
that pretreatment of Ang II on insulin disrupted
stress fiber formation.
Fig. 5．MMPs are not involved in Ang II-induced inhibition of
actin stress fiber formation.
L6 cells were treated with GM 6001(GM), a compound that
broadly inhibits MMP activation, for 10 min before Ang II or
pretreatment of Ang II (Ang II, Ins.). A : Actin filaments were
observed under fluorescence microscope. B : Representative
blots of Akt phosphorylation (pAkt), total Akt (Akt), ERK 1/2
phosphorylation (pERK 1/2)and total ERK 1/2(ERK 1/2). C :
Densitometry analyses of pERK 1/2. Values are normalized by
arbitrarily setting the densitometry of control cells (without
any stimulation) to 1(values are the mean±SD, n=3).＊P<0.05
vs. control cells.
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It is thought that AT1 receptor ligand binding
causes activation of ERKs through three distinct
signaling pathways. One pathway is via the Gq-PKC-
dependent mechanism, another is via the Src-Ras-
dependent mechanism, and the third pathway is
by trans-activation of the epidermal growth factor
receptor (6, 15-24).
MMPs are zinc-dependent endopeptidases com-
prising mainly the collagenases, gelatinases, stro-
melysins, and membrane-type MMP. EGFR phos-
phorylation and downstream signaling have been
shown to be dependent on MMP activity in many
systems. Ang II can transactivate receptor tyrosine
kinases (RTK), even though Ang II does not bind
directly to RTK. In the present study we provided
evidences that Ang II induces ERK 1/2 activation
not through Gq-dependent mechanisms or trans-
activation of the epidermal growth factor receptor
in L6 cells. This phenomenon occurs in cross talk
to Akt activation and consequently actin organization
and glucose uptake from Src-dependent-ERK 1/2
signaling pathway. Intracellular interactions between
different signaling systems may function as mecha-
nisms for enhancing or counter regulating hormone
action. In the case of Ang II, the crosstalk with
insulin-mediated pathways resulted in negative
interactions between Ang II and insulin signaling
systems at the ERKs.
We also found that insulin causes ERK 1/2
phosphorylation as well as Ang II. Simultaneous
stimulation with both hormones led to increased
dually phosphorylated ERKs. In contrast, reduc-
tion of PDK-1 phosphorylation (data not shown)
and Akt phosphorylation was observed compared
with that after Ang II administration. The precise
mechanism for this difference is not known ; how-
ever, possibilities include differential sites of serine
and theronine phosphorylation on ERK 1/2 pro-
teins after Ang II plus insulin treatment leading to
an impairment of the PDK-1/Akt pathway. Inter-
estingly, insulin action on glucose uptake was
slightly but significantly enhanced by an ERK 1/2
inhibitor. Thus, phosphorylation of ERK 1/2 by
insulin might have an inhibitory effect on glucose
uptake or actin reorganization, although main path-
way of insulin via PI3-K/Akt enhances glucose uptake
and actin reorganization.
Finally, these data provide a novel insight into the
Ang II signaling mechanism leading to inhibited
insulin-induced actin fiber organization consequently
glucose uptake. We establish a correlative relation-
ship between a proximal signaling event (the acti-
vation of ERKs) and a distal cellular response (cy-
toskeleton organization). Furthermore, detecting
a putative signaling pathway bywhich ERK 1/2 exerts
this anti-diabetic effect in the clinically important
skeletal muscle cell.
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